about
Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patientsA greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles.Live birth in a 46 year old using autologous oocytes cryopreserved for a duration of 3 years: a case report documenting fertility preservation at an advanced reproductive ageClinical utilisation of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantationOocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors.Assessing morphokinetic parameters via time lapse microscopy (TLM) to predict euploidy: are aneuploidy risk classification models universal?Fertility and maternal age strategies to improve pregnancy outcome.Evaluation of Vero cell co-culture system for mouse embryos in various media.Pregnancy derived from human zygote pronuclear transfer in a patient who had arrested embryos after IVF.Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle.Comparison of pregnancy outcomes in elective single blastocyst transfer versus double blastocyst transfer stratified by age.A comparison of pregnancy outcomes between day 3 and day 5/6 embryo transfers: does day of embryo transfer really make a difference?Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 yearsIn vitro fertilization with preimplantation genetic screening improves implantation and live birth in women age 40 through 43.Is there an androgen level threshold for aneuploidy risk in infertile women?Chromosome abnormalities in human arrested preimplantation embryos: a multiple-probe FISH study.Serum progesterone levels greater than 20 ng/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates.Supernumerary blastocyst cryopreservation: a key prognostic indicator for patients opting for an elective single blastocyst transfer (eSBT).Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile populationPreimplantation genetic diagnosis of human embryos for Marfan's syndromeMitochondrial DNA quantification as a tool for embryo viability assessment: retrospective analysis of data from single euploid blastocyst transfers.Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation.Is what we clearly see really so obvious? Ultrasonography and transcervical embryo transfer--a review.Shutoff of host translation by encephalomyocarditis virus infection does not involve cleavage of the eucaryotic initiation factor 4F polypeptide that accompanies poliovirus infectionDiscrepant diagnosis rate of array comparative genomic hybridization in thawed euploid blastocysts.Live birth from previously vitrified oocytes, after trophectoderm biopsy, revitrification, and transfer of a euploid blastocyst.Ectopic pregnancy rates after in vitro fertilization: a look at the donor egg population.Fate of cryopreserved donor embryos.Chlamydia trachomatis detected by polymerase chain reaction in cervices of culture-negative women correlates with adverse in vitro fertilization outcome.Unsuspected Chlamydia trachomatis infection and in vitro fertilization outcome.Analysis of Oct-4 expression and ploidy in individual human blastomeres.Detailed investigation into the cytogenetic constitution and pregnancy outcome of replacing mosaic blastocysts detected with the use of high-resolution next-generation sequencing.Delayed intracytoplasmic sperm injection (ICSI) with trophectoderm biopsy and preimplantation genetic screening (PGS) show increased aneuploidy rates but can lead to live births with single thawed euploid embryo transfer (STEET).The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologistsElective oocyte cryopreservation for deferred childbearing.Diagnosis and clinical management of embryonic mosaicism.Isolated teratozoospermia does not affect in vitro fertilization outcome and is not an indication for intracytoplasmic sperm injection.Serum progesterone trend after day of transfer predicts live birth in fresh IVF cycles.Gestational carrier pregnancy with oocytes obtained during surgery for stage IIIc ovarian cancer after controlled ovarian stimulation.Preimplantation diagnosis of genetic and chromosomal disorders.
P50
Q28244823-B1037BD6-1B65-41FF-A6C1-05CBCF03EA26Q33722006-C421F37D-AD0C-473B-9873-5ADF1A9FCEB1Q33722036-71913ADD-42FA-4B09-8887-2E4592B882E4Q33956545-3B7F1EA6-C03B-4EF7-847D-3C386CF29B45Q34138083-63097756-365E-44EB-98EA-E4C804986F27Q34145778-DC8DABD1-12D6-429F-9D5D-810E2E913E54Q34397252-19375FD5-2041-4623-8B42-4EA8CB37BEB4Q34404798-96D6A555-50D7-4C8A-96EB-E4A7F91D04C9Q34537325-BD091522-F33E-4BAF-9DB6-872986826BD7Q34688687-49F600B2-E421-4794-AC3E-867A70D67A09Q34953904-A1F52D76-63BD-4CD0-ACBC-044B880169F3Q35160865-2E734A34-7289-458C-AC9D-536EDBC1D402Q35181946-E97CC55F-5A3F-40E4-BB07-DA5754EC4B84Q35186895-0C621F51-E331-4DCD-95A3-9F085C6A707BQ35626377-5EA7644E-DE78-4EE7-BB1D-5752A629C8E1Q35889306-1CD33525-3579-468B-9975-5BB17E49F9EFQ36127719-A3CEE254-3E0C-4802-9B1F-7AFB8FB409FBQ36198811-5A54AC4B-8A98-4717-B4D7-2D7E7322B3CFQ36198884-56C7684E-F3DB-4580-BF63-0CE77164C2DFQ36267659-4F5361B6-EF4A-451A-AF69-FC927E44C840Q36339551-E4156B09-419D-4B03-A971-A6DBACB54922Q36648713-04D17522-6365-402B-9EAF-8D5F26EA7731Q36649119-603A3BD5-942A-4696-9CC0-066F9289CCC5Q36901762-1E5A63C5-030E-4F79-8802-6BA1BF75CF51Q37059959-B2CF5EAE-076D-4C84-A8FE-E1F7455CFFD9Q37463046-E769B40B-BC2D-4CF6-AAE4-70509A8F6D6CQ37518740-48E1FEA7-0000-4AA6-A5C7-343E1AE5AFAAQ37670377-CAB02B88-17CD-428B-BC9F-DD747FC68E04Q37886980-BBC1646C-CEE8-4BC0-9AF6-EB635FD6CEEDQ37888084-98069E4F-F93D-4DC4-A8A4-2D1FDF4D6067Q38304676-4241E249-0D07-4DFD-BE59-250174F363B6Q38745729-4277D9E5-C625-4974-A232-9C687A07CBD2Q38851879-22AD5DD0-C60D-4001-85B5-142F3D9ABB8DQ38852215-F6C66078-B1EF-4EEA-9846-A5702D449D94Q38965545-39819966-FE7D-4C74-BE2A-44BADD8E202AQ39008587-A78F6A01-6B18-46CC-B127-4F385175FE06Q40221320-740895D8-1A58-498D-AEE3-6B61A37DE771Q40382521-77C0F84B-97AF-4807-8FEF-3AF0856F0A29Q40426004-802FFB6B-5169-4C87-BFC8-950DF9CDDA12Q40503595-9F22928A-42BA-4423-ACB0-0636BB1BB1EF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
James A. Grifo
@ast
James A. Grifo
@en
James A. Grifo
@es
James A. Grifo
@nl
James A. Grifo
@sl
type
label
James A. Grifo
@ast
James A. Grifo
@en
James A. Grifo
@es
James A. Grifo
@nl
James A. Grifo
@sl
prefLabel
James A. Grifo
@ast
James A. Grifo
@en
James A. Grifo
@es
James A. Grifo
@nl
James A. Grifo
@sl
P106
P1153
7005818600
P21
P31
P496
0000-0003-0439-2374